Skip to main content

Latest SEC Filings — Page 114

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Ameresco CFO Mark Chiplock Resigns Effective September 25; Company Reiterates FY2026 Guidance
Form 8-KAMRC · Form 8-K · 2026-08-19
Brinker Boosts Buyback to $750M, Adds Director Departure and $27.5M Acquisition
Form 10-KEAT · Form 10-K · 2026-08-19
Aurinia Settles Teva Patent Litigation, Secures LUPKYNIS Exclusivity Until December 2036
ProForm 8-KAUPH · Form 8-K · 2026-08-19
Firy Q2 Revenue Up 23%, But Material Weakness in Controls Disclosed
ProForm 10-QFIRY · Form 10-Q · 2026-08-19
Onfolio Settles $8.2M Floor Penalty and Converts $5.5M Notes, Issues 1.58M Shares
ProForm 10-QONFO · Form 10-Q · 2026-08-19
GameSquare Finalizes 1-for-8 Reverse Split Effective August 24
Form 8-KGAME · Form 8-K · 2026-08-19
Genpact Seeks Shareholder Nod for Delaware Domestication
Form S-4G · Form S-4 · 2026-08-19
OZOP Q2 Loss Balloons to $8.4M as Derivative Liabilities Double and Cash Dwindles to $60K
ProForm 10-QOZSC · Form 10-Q · 2026-08-19
Beasley Broadcast Group Lays Out FY2026–2028 Path: Revenue Recovery to $202.5M, Adjusted EBITDA to $29.8M
Form 8-KBBGI · Form 8-K · 2026-08-19
Golden Sun Posts 30% Revenue Growth but Flags Going Concern Doubts
ProForm 6-KGSUN · Form 6-K · 2026-08-19
ModuLink Q2 2026: Going Concern Warning, $280K Loss, $300K Preferred Raise
ProForm 10-QMDLK · Form 10-Q · 2026-08-19
DBGI Q2 2026: Going Concern Doubt, $20.4M Loss, and $100M Equity Line
ProForm 10-QDBGI · Form 10-Q · 2026-08-19
TLSS 10-Q: Going Concern, $645K Loss, and 11B Share Overhang
ProForm 10-QTLSS · Form 10-Q · 2026-08-19
Biotricity Q1 FY2027: Revenue Climbs 10%, Yet Going Concern and Series C Exchange Loom
ProForm 10-QBTCY · Form 10-Q · 2026-08-19
LQR House 10-Q Reveals Going Concern, Material Weaknesses, and $41M ATM Capacity
ProForm 10-QYHC · Form 10-Q · 2026-08-19
Top KingWin Posts $19.6M H1 Loss After Full Write-Off of $39.6M Supplier Prepayments
ProForm 6-KDPU · Form 6-K · 2026-08-19
SVAQ and EigenQ Submit Draft S-4, Target Q4 2026 Close
Form 8-KSVAQ · Form 8-K · 2026-08-19
Edesa Biotech Launches Public Offering with Warrants Tied to EB06 Data
Form 424B5EDSA · Form 424B5 · 2026-08-19
Opendoor Finalizes $650M Convertible Note Offering with 35% Conversion Premium
ProForm 8-KOPEN · Form 8-K · 2026-08-19
OneMedNet Sets September 18 Vote on Reverse Split and Equity Plan Expansion
Form DEF 14AONMD · Form DEF 14A · 2026-08-19
Sunrise Q2 Revenue Dips 2.6% but FCF Jumps 33%; 2026 Guidance Reconfirmed
Form 6-KSNNRF · Form 6-K · 2026-08-19
Korro Bio Files for KRRO-121 Phase 1/2 Trial in Australia
Form 8-KKRRO · Form 8-K · 2026-08-19
VisionWave Posts $45.8M Loss, Cites Funding Support to Ease Going Concern, and Secures $15M Convertible Financing
ProForm 10-QVWAV · Form 10-Q · 2026-08-19
Accuray Q4 Revenue Falls 21%, Withdraws FY27 Guidance Amid Recapitalization
ProForm 8-KARAY · Form 8-K · 2026-08-19
Gorilla Registers $125M Series B Convertible Notes for Resale
Form F-3/AGRRR · Form F-3/A · 2026-08-19
Bravo Multinational Reports $210K Loss, $2.3K Cash, and Material Weakness
ProForm 10-QBRVO · Form 10-Q · 2026-08-19
Crinetics Discloses Shareholder Lawsuits and Supplemental Proxy Details Ahead of Vertex Merger Vote
Form 8-KCRNX · Form 8-K · 2026-08-19
HCMC Flags Going Concern, Material Weaknesses in Q2 Report
ProForm 10-QHCMC · Form 10-Q · 2026-08-19
Beam Global Q2 Revenue Rebounds 21% but Material Weaknesses Persist
ProForm 10-QBEEM · Form 10-Q · 2026-08-19
LivePerson Urges Final Shareholder Vote on SoundHound AI Merger Today
ProForm 425LPSN · Form 425 · 2026-08-19